1997
DOI: 10.1055/s-2007-996134
|View full text |Cite
|
Sign up to set email alerts
|

The INR: A Perspective

Abstract: The use of oral anticoagulants to treat and prevent thromboembolic disease has been a major medical development and has largely been made practicable by the introduction of the prothrombin time as a method for monitoring patients during therapy. Unfortunately, despite many years of application, the administration of oral anticoagulants is still fraught with complications. This has been partly a consequence of the absence of a uniform method of performing and comparing prothrombin times from one laboratory to a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Because of individual laboratory reagent variability and the desire to be able to reliably compare the PT from one laboratory to that from another, the PT test is now commonly reported with its INR. 15,16 The INR, introduced by the World Health Organization in 1983, is the ratio of PT that adjusts for the sensitivity of the thromboplastin reagents, such that a normal coagulation profile is reported as an INR of 1.0. 17 This test evaluates the extrinsic coagulation system and measures the presence or absence of clotting Fs I, II, V, VII, and X.…”
Section: Clinical Laboratory Testsmentioning
confidence: 99%
“…Because of individual laboratory reagent variability and the desire to be able to reliably compare the PT from one laboratory to that from another, the PT test is now commonly reported with its INR. 15,16 The INR, introduced by the World Health Organization in 1983, is the ratio of PT that adjusts for the sensitivity of the thromboplastin reagents, such that a normal coagulation profile is reported as an INR of 1.0. 17 This test evaluates the extrinsic coagulation system and measures the presence or absence of clotting Fs I, II, V, VII, and X.…”
Section: Clinical Laboratory Testsmentioning
confidence: 99%
“…This variation was demonstrated to be due to the differences in activity of the thromboplastins used. [9][10][11] This led to international standardization efforts that demonstrated a more harmonized outcome when the different thromboplastins were compared with a reference thromboplastin reagent and assigned a sensitivity index, the international sensitivity index (ISI). This was used to derive the international normalized ratio (INR) which rapidly gained approval by the international coagulation community.…”
mentioning
confidence: 99%